ABBOTT LABORATORIES·4

Feb 23, 8:29 PM ET

PEDERSON MICHAEL J 4

4 · ABBOTT LABORATORIES · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-18
PEDERSON MICHAEL J
Senior Vice President
Transactions
  • Award

    Common shares without par value

    2022-02-18+8,73571,306 total
  • Award

    Option (right to buy)

    2022-02-18+40,71040,710 total
    Exercise: $117.58From: 2023-02-18Exp: 2032-02-17Common Shares (40,710 underlying)
Holdings
  • Common shares without par value

    (indirect: By Spouse)
    75
Footnotes (2)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,570 on February 18, 2023, 13,570 on February 18, 2024, and 13,570 on February 18, 2025.

Documents

1 file
  • 4
    form4-02232022_050219.xmlPrimary